Diagnostic and Prognostic Relevance of Red Blood Cell Distribution Width for Vascular Aging and Cardiovascular Diseases

Rejuvenation Research

Volumn 22, Issue 2, 2019, Pages 146-162

  Poz, Donatella ^a   De Falco, Elena ^b   Pisano, Calogera ^c   Madonna, Rosalinda ^d,e,f   Ferdinandy, Peter ^g,h   Balistreri, Carmela Rita ⁱ  

^a University of Udine   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^d ST LUKE S EPISCOPAL HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF CHIETI   (Italy)

^g SEMMELWEIS UNIVERSITY   (Hungary)

^h PHARMAHUNGARY GROUP   (Hungary)

ⁱ UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGING; CARDIOVASCULAR DISEASE; CELL AGING; CELL REGENERATION; DIAGNOSTIC VALUE; ENDOTHELIAL PROGENITOR CELL; ERYTHROCYTE; EVALUATION STUDY; HUMAN; LEUKOCYTE; PRIORITY JOURNAL; PROGNOSIS; RED BLOOD CELL DISTRIBUTION WIDTH; REVIEW; TELOMERE LENGTH; BLOOD; GENETIC EPIGENESIS; MEAN CORPUSCULAR VOLUME;

AGING; BIOMARKERS; CARDIOVASCULAR DISEASES; EPIGENESIS, GENETIC; ERYTHROCYTE INDICES; HUMANS; PROGNOSIS;

EID: 85064541309     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2018.2094     Document Type: Review

References (171)

1. Price-Jones C. Red Blood Cell Diameters. London: Humphrey Milford, Oxford University Press, 1933, p. 102.
2. Bain BJ. Basic Hematological Techniques. In: Elsevier, (ed): Dacie and LEwis Practical Hematology. 11th ed. Edinburgh, Churchill Livingstone, 2012.
3. McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Mangment by Laboratory Methods. 22nd ed. Philadelphia, Elsevier, 2011, p. 1568.
4. McLaren CE, Houwen B, Koepke JA, Rowan RM, McKay PJ, Ortner BR, Bishop ML. Analysis of red blood cell volume distributions using the ICSH reference method: Detection of sequential changes in distributions determined by hydrodynamic focusing. Clin Lab Haematol 1993;15:12.
5. ICSH recommendations for the analysis of red cell, white cell and platelet size distribution curves. Methods for fitting a single reference distribution and assessing its goodness of fit. International Committee for Standardization in Haematology. ICSH Expert Panel on Cytometry. Clin Lab Haematol 1990;12:417-431.
6. Buttarello M, Plebani M. Automated blood cell counts: State of the art. Am J Clin Pathol 2008;130:104-116.
7. Lippi G, Pavesi F, Bardi M, Pipitone S. Lack of harmonization of red blood cell distribution width (RDW). Evaluation of four hematological analyzers. Clin Biochem 2014;47:1100-1103.
8. Bessman JD, Gilmer PR, Jr., Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol 1983;80:322-326.
9. Flynn MM, Reppun TS, Bhagavan NV. Limitations of red blood cell distribution width (RDW) in evaluation of microcytosis. Am J Clin Pathol 1986;85:445-449.
10. Bessman JD, Gilmer PR, Jr., Gardner FH. Too early to put down RDW for discriminating iron deficiency and thalassemia. Am J Clin Pathol 1986;86:693-695.
11. Cappelletti P. Linee guida per il referto ematologico-GdSE-SIMEL. Riv Med Lab-JLM 2002;3:7.
12. Sahli CA, Bibi A, Ouali F, et al. Red cell indices: Differentiation between beta-thalassemia trait and iron deficiency anemia and application to sickle cell disease and sickle cell thalassemia. Clin Chem Lab Med 2013;51: 1595-1603.
13. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009;133:628-632.
14. Fukuta H, Ohte N, Mukai S, et al. Elevated plasma levels of B-type natriuretic Peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J 2009;50: 301-312.
15. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: Data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007;50:40-47.
16. Abrahan LL 4th, Ramos JDA, Cunanan EL, Tiongson MDA, Punzalan FER. Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis. Cardiol Res 2018;9:144-152.
17. Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Int Med 2009; 169:588-594.
18. Allen LA, Felker GM, Mehra MR, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 2010;16: 230-238.
19. Makhoul BF, Khourieh A, Kaplan M, Bahouth F, Aronson D, Azzam ZS. Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure. Int J Cardiol 2013;167:1412-1416.
20. Fried W. Erythropoietin and erythropoiesis. Exp Hematol 2009;37:1007-1015.
21. Lippi G, Franchini M, Salvagno GL, Guidi GC. Biochemistry, physiology, and complications of blood doping: Facts and speculation. Critic Rev Clin Lab Sci 2006; 43:349-391.
22. Kario K, Matsuo T, Nakao K, Yamaguchi N. The correlation between red cell distribution width and serum erythropoietin titres. Clin Lab Haematol 1991;13:222-223.
23. Afsar B, Saglam M, Yuceturk C, Agca E. The relationship between red cell distribution width with erythropoietin resistance in iron replete hemodialysis patients. Eur J Int Med 2013;24:e25-29.
24. Cheng CK, Chan J, Cembrowski GS, van Assendelft OW. Complete blood count reference interval diagrams derived from NHANES III: Stratification by age, sex, and race. Lab Hematol 2004;10:42-53.
25. Alattar FT, Imran NB, Patel P, Usmani S, Shamoon FE. Red cell distribution width (RDW) correlates with markers of diastolic dysfunction in patients with impaired left ventricular systolic function. Int J Cardiol Heart Vasc 2016;10:13-16.
26. Chen PC, Sung FC, Chien KL, Hsu HC, Su TC, Lee YT. Red blood cell distribution width and risk of cardiovascular events and mortality in a community cohort in Taiwan. Am J Epidemiol 2010;171:214-220.
27. Qiao R, Yang S, Yao B, Wang H, Zhang J, Shang H. Complete blood count reference intervals and age-and sex-related trends of North China Han population. Clin Chem Lab Med 2014;52:1025-1032.
28. Borne Y, Smith JG, Melander O, Engstrom G. Red cell distribution width in relation to incidence of coronary events and case fatality rates: A population-based cohort study. Heart 2014;100:1119-1124.
29. Lippi G, Salvagno GL, Guidi GC. Red blood cell distribution width is significantly associated with aging and gender. Clin Chem Lab Med 2014;52:e197-199.
30. Alis R, Fuster O, Rivera L, Romagnoli M, Vaya A. Influence of age and gender on red blood cell distribution width. Clin Chem Lab Med 2015;53:e25-28.
31. Hoffmann JJ, van den Broek NM, Curvers J. Reference intervals of extended erythrocyte and reticulocyte parameters. Clin Chem Lab Med 2012;50:941-948.
32. Hoffmann JJ, Nabbe KC, van den Broek NM. Effect of age and gender on reference intervals of red blood cell distribution width (RDW) and mean red cell volume (MCV). Clin Chem Lab Med 2015;53:2015-2019.
33. Codd V, Nelson CP, Albrecht E, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 2013;45:422-427, 7e1-2.
34. Xi Q, Liu Z, Zhao Z, Luo Q. Red blood cell distribution width predicts responsiveness of acute pulmonary vasodilator testing in patients with idiopathic pulmonary arterial hypertension. Clin Chim Acta 2015;446:272-276.
35. Saxena S, Wong ET. Heterogeneity of common hematologic parameters among racial, ethnic, and gender subgroups. Arch Pathol Lab Med 1990;114:715-719.
36. Zalawadiya SK, Veeranna V, Panaich SS, Afonso L, Ghali JK. Gender and ethnic differences in red cell distributionwidth and its association with mortality among low risk healthy United state adults. Am J Cardiol 2012;109:1664-1670.
37. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA 1997;277:973-976.
38. Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005;46:464-469.
39. Loprinzi PD, Loenneke JP, Ahmed HM, Blaha MJ. Sex and race-ethnicity secular trends in mean and elevated red blood cell distribution width among adults in the United States, 1999-2012. Ethn Dis 2016;26:45-50.
40. Fujita B, Strodthoff D, Fritzenwanger M, et al. Altered red blood cell distribution width in overweight adolescents and its association with markers of inflammation. Pediatr Obes 2013;8:385-391.
41. Vayá A, Alis R, Hernandez-Mijares A, et al. Red blood cell distribution width is not related with inflammatory parameters in morbidly obese patients. Clin Biochem 2014;47:464-466.
42. Laufer Perl M, Havakuk O, Finkelstein A, et al. High red blood cell distribution width is associated with the metabolic syndrome. Clin Hemorheol Microcirc 2015;63:35-43.
43. Furuncuog?lu Y, Tulgar S, Dogan AN, Cakar S, Tulgar YK, Cakiroglu B. How obesity affects the neutrophil/ lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: A retrospective study. Eur Rev Med Pharmacol Sci 2016;20: 1300-1306.
44. Pilling LC, Atkins JL, Duff MO, et al. Red blood cell distribution width: Genetic evidence for aging pathways in 116, 666 volunteers. PLoS One 2017;12:e0185083.
45. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013;153:1194-1217.
46. Lippi G, Sanchis-Gomar F, Danese E, Montagnana M. Association of red blood cell distribution width with plasma lipids in a general population of unselected outpatients. Kardiol Pol 2013;71:931-936.
47. Balistreri CR, Ruvolo G, Lio D, Madonna R. Toll-like receptor-4 signaling pathway in aorta aging and diseases: ''its double nature. '' J Mol Cell Cardiol 2017;110:38-53.
48. Pisano C, Balistreri CR, Ricasoli A, Ruvolo G. Cardiovascular disease in ageing: An overview on thoracic aortic aneurysm as an emerging inflammatory disease. Mediat Inflamm 2017;2017:1274034.
49. Fyhrquist FY, Saijonmaa OJ. Modifiable factors influencing telomere lenght and aging. In: Springer, (ed): Inflammation, Aging, and Oxidative Stress. 1st ed: New York, Humana Press, 2016, pp. 67-80.
50. Telomeres Mendelian Randomization C, Haycock PC, Burgess S, et al. Association between telomere length and risk of cancer and non-neoplastic diseases: A Mendelian Randomization Study. JAMA Oncol 2017;3:636-651.
51. Kozlitina J, Garcia CK. Red blood cell size is inversely associated with leukocyte telomere length in a large multiethnic population. PLoS One 2012;7:e51046.
52. Tammen SA, Friso S, Choi SW. Epigenetics: The link between nature and nurture. Mol Aspects Med 2013;34: 753-764.
53. Mirando MA, Swanson KS. Companion Animals Symposium: Nutrition special needs-the relationship between novel ingredients, environment, and gene expression. J Anim Sci 2013;91:2947-2948.
54. Fairfax BP, Knight JC. Genetics of gene expression in immunity to infection. Curr Opin Immunol 2014;30:63-71.
55. Rosa-Garrido M, Chapski DJ, Vondriska TM. Epigenomes in cardiovascular disease. Circ Res 2018;122:1586-1607.
56. Nahrendorf M, Swirski FK. Lifestyle effects on hematopoiesis and atherosclerosis. Circ Res 2015;116:884-894.
57. Emans ME, Gaillard CA, Pfister R, et al. Red cell distribution width is associated with physical inactivity and heart failure, independent of established risk factors, inflammation or iron metabolism; the EPIC-Norfolk study. Int J Cardiol 2013;168:3550-3555.
58. Loprinzi PD, Loenneke JP, Abe T. The association between muscle strengthening activities and red blood cell distribution width among a national sample of U. S. adults. Prev Med 2015;73:130-132.
59. Lippi G, Salvagno GL, Danese E, Tarperi C, Guidi GC, Schena F. Variation of red blood cell distribution width and mean platelet volume after moderate endurance exercise. Adv Hematol 2014;2014:192173.
60. Loprinzi PD, Hall ME. Physical activity and dietary behavior with red blood cell distribution width. Physiol Behav 2015;149:35-38.
61. Saffar Soflaei S, Darroudi S, Tayefi M, et al. Hookah smoking is strongly associated with diabetes mellitus, metabolic syndrome and obesity: A population-based study. Diabetol Metab Syndr 2018;10:33.
62. Karvellas CJ, Sawyer M, Hamilton M, Mackey JR. Effect of capecitabine on mean corpuscular volume in patients with metastatic breast cancer. Am J Clin Oncol 2004;27: 364-368.
63. Wenzel C, Mader RM, Steger GG, et al. Capecitabine treatment results in increased mean corpuscular volume of red blood cells in patients with advanced solid malignancies. Anticancer Drugs 2003;14:119-123.
64. Pham AQ, Xu LH, Moe OW. Drug-induced metabolic acidosis. F1000Research 2015;4.
65. Tonelli M, Sacks F, Arnold M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008;117: 163-168.
66. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-1023.
67. Kiefer CR, Snyder LM. Oxidation and erythrocyte senescence. Curr Opin Hematol 2000;7:113-116.
68. Friedman JS, Lopez MF, Fleming MD, et al. SOD2-deficiency anemia: Protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood 2004;104:2565-2573.
69. Semba RD, Patel KV, Ferrucci L, et al. Serum antioxidants and inflammation predict red cell distribution width in older women: The Women's Health and Aging Study I. Clin Nutr 2010;29:600-604.
70. Sousa R, Goncalves C, Guerra IC, et al. Increased red cell distribution width in Fanconi anemia: A novel marker of stress erythropoiesis. Orphanet J Rare Dis 2016;11:102.
71. Kimber C, Deller DJ, Ibbotson RN, Lander H. The mechanism of anaemia in chronic liver disease. Q J Med 1965;34:33-64.
72. Liu Z, Feng Q, Sun P, et al. Genome-wide DNA methylation drives human embryonic stem cell erythropoiesis by remodeling gene expression dynamics. Epigenomics 2017;9:1543-1558.
73. van Rooij FJA, Qayyum R, Smith AV, et al. Genomewide Trans-ethnic Meta-analysis Identifies Seven Genetic Loci Influencing Erythrocyte Traits and a Role for RBPMS in Erythropoiesis. Am J Hum Genet 2017;100: 51-63.
74. Papageorgiou DN, Karkoulia E, Amaral-Psarris A, et al. Distinct and overlapping DNMT1 interactions with multiple transcription factors in erythroid cells: Evidence for co-repressor functions. Biochim Biophys Acta 2016;1859: 1515-1526.
75. Yao H, Goldman DC, Fan G, Mandel G, Fleming WH. The corepressor Rcor1 is essential for normal myeloerythroid lineage differentiation. Stem Cells 2015;33:3304-3314.
76. Ginder GD. Epigenetic regulation of fetal globin gene expression in adult erythroid cells. Transl Res 2015;165: 115-125.
77. Wallace RG, Twomey LC, Custaud MA, et al. The role of epigenetics in cardiovascular health and ageing: A focus on physical activity and nutrition. Mech Ageing Dev 2017;pii:S0047-637430233-30236.
78. Saliba W, Barnett-Griness O, Elias M, Rennert G. The association between red cell distribution width and stroke in patients with atrial fibrillation. Am J Med 2015;128:192 e11-18.
79. Danese E, Lippi G, Montagnana M. Red blood cell distribution width and cardiovascular diseases. J Thorac Dis 2015;7:E402-411.
80. Lippi G, Filippozzi L, Montagnana M, et al. Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin Chem Lab Med 2009;47:353-357.
81. Skjelbakken T, Lappegard J, Ellingsen TS, et al. Red cell distribution width is associated with incident myocardial infarction in a general population: The Tromso Study. J Am Heart Assoc 2014;3.
82. Hu GX, Zhang J, Tian YG, Li YH, Mou L, Qiao LJ. Diagnostic value of joint detection of homocysteine and RDW CV on acute myocardial infarction. Eur Rev Med Pharmacol Sci 2016;20:4124-4128.
83. Bujak K, Wasilewski J, Osadnik T, et al. The prognostic role of red blood cell distribution width in coronary artery disease: A review of the pathophysiology. Dis Markers 2015;2015:824624.
84. Uyarel H, Ergelen M, Cicek G, et al. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis 2011;22:138-144.
85. Gul M, Uyarel H, Ergelen M, et al. The relationship between red blood cell distribution width and the clinical outcomes in non-ST elevation myocardial infarction and unstable angina pectoris: A 3-year follow-up. Coron Artery Dis 2012;23:330-336.
86. Sun XP, Chen WM, Sun ZJ, et al. Impact of red blood cell distribution width on long-term mortality in patients with ST-elevation myocardial infarction. Cardiology 2014;128: 343-348.
87. Tuncez A, Cetin MS, Cetin EH, Yilmaz S, Korkmaz A, Ucar FM. Association between RDW and stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Medicine 2017;96:e5986.
88. Lippi G, Cervellin G. Risk assessment of postinfarction heart failure. Systematic review on the role of emerging biomarkers. Critic Rev Clin Lab Sci 2014; 51:13-29.
89. Inuzuka R, Abe J. Red blood cell distribution width as a link between ineffective erythropoiesis and chronic inflammation in heart failure. Circ J 2015;79:974-975.
90. Tseliou E, Terrovitis JV, Kaldara EE, et al. Red blood cell distribution width is a significant prognostic marker in advanced heart failure, independent of hemoglobin levels. Hellenic J Cardiol 2014;55:457-461.
91. Dai Y, Konishi H, Takagi A, Miyauchi K, Daida H. Red cell distribution width predicts short-and long-term outcomes of acute congestive heart failure more effectively than hemoglobin. Exp Ther Med 2014;8:600-606.
92. Liu S, Wang P, Shen PP, Zhou JH. Predictive values of red blood cell distribution width in assessing severity of chronic heart failure. Med Sci Monit 2016;22:2119-2125.
93. Adamsson Eryd S, Borne Y, Melander O, et al. Red blood cell distribution width is associated with incidence of atrial fibrillation. J Int Med 2014;275:84-92.
94. Gungor B, Ozcan KS, Erdinler I, et al. Elevated levels of RDW is associated with non-valvular atrial fibrillation. J Thromb Thrombolysis 2014;37:404-410.
95. Liu T, Shao Q, Miao S, et al. Red cell distribution width as a novel, inexpensive marker for paroxysmal atrial fibrillation. Int J Cardiol 2014;171:e52-53.
96. Chaikriangkrai K, Valderrabano M, Bala SK, et al. Prevalence and implications of subclinical coronary artery disease in patients with atrial fibrillation. Am J Cardiol 2015;116:1219-1223.
97. Ertas G, Aydin C, Sonmez O, et al. Red cell distribution width predicts new-onset atrial fibrillation after coronary artery bypass grafting. Scand Cardiovasc J 2013;47:132-135.
98. Korantzopoulos P, Liu T. RDW as a marker of postoperative atrial fibrillation. Int J Cardiol 2015;191:109.
99. Balta S, Demir M, Demirkol S, Arslan Z, Unlu M, Celik T. Red cell distribution width is related to stroke in patients with heart failure. Clin Appl Thromb Hemost 2015; 21:190.
100. Kaya A, Isik T, Kaya Y, et al. Relationship between red cell distribution width and stroke in patients with stable chronic heart failure: A propensity score matching analysis. Clin Appl Thromb Hemost 2015;21:160-165.
101. Soderholm M, Borne Y, Hedblad B, Persson M, Engstrom G. Red cell distribution width in relation to incidence of stroke and carotid atherosclerosis: A population-based cohort study. PLoS One 2015;10:e0124957.
102. Demir R, Saritemur M, Atis O, et al. Can we distinguish stroke and stroke mimics via red cell distribution width in young patients? Arch Med Sci 2015;11:958-963.
103. Jia H, Li H, Zhang Y, Li C, Hu Y, Xia C. Association between red blood cell distribution width (RDW) and carotid artery atherosclerosis (CAS) in patients with primary ischemic stroke. Arch Gerontol Geriatr 2015;61: 72-75.
104. Turcato G, Cappellari M, Follador L, et al. Red blood cell distribution width is an independent predictor of outcome in patients undergoing thrombolysis for ischemic stroke. Semin Thromb Hemost 2017;43:30-35.
105. Haltmayer M, Mueller T, Luft C, Poelz W, Haidinger D. Erythrocyte mean corpuscular volume associated with severity of peripheral arterial disease: An angiographic evaluation. Ann Vasc Surg 2002;16:474-479.
106. Mueller T, Luft C, Haidinger D, Poelz W, Haltmayer M. Erythrocyte mean corpuscular volume associated with the anatomical distribution in peripheral arterial disease. VASA 2002;31:81-85.
107. Zalawadiya SK, Veeranna V, Panaich SS, Afonso L. Red cell distribution width and risk of peripheral artery disease: Analysis of National Health and Nutrition Examination Survey 1999-2004. Vasc Med 2012;17: 155-163.
108. Ark HYV. Red cell distribution width predicts length of stay in patients with acutely decompensated heart failure. Eur J Health Sci 2015;1:8.
109. Su C, Liao LZ, Song Y, Xu ZW, Mei WY. The role of red blood cell distribution width in mortality and cardiovascular risk among patients with coronary artery diseases: A systematic review and meta-analysis. J Thorac Dis 2014; 6:1429-1440.
110. Li N, Zhou H, Tang Q. Red blood cell distribution width: A novel predictive indicator for cardiovascular and cerebrovascular diseases. Dis Markers 2017;2017:7089493.
111. Huang YL, Hu ZD, Liu SJ, et al. Prognostic value of red blood cell distribution width for patients with heart failure: A systematic review and meta-analysis of cohort studies. PLoS One 2014;9:e104861.
112. Luo R, Hu J, Jiang L, Zhang M. Prognostic value of red blood cell distribution width in non-cardiovascular critically or acutely patients: A systematic review. PLoS One 2016;11:e0167000.
113. Lippi G. Red blood cell distribution width and mean platelet volume: Surrogate markers for, or treatment targets in, dyslipidemia? Clin Biochem 2015;48:555-556.
114. Sarikaya S, Sahin S, Akyol L, et al. Is there any relationship between RDW levels and atrial fibrillation in hypertensive patient? Afr Health Sci 2014;14:267-272.
115. Duchnowski P, Hryniewiecki T, Kusmierczyk M, Szymanski P. Red cell distribution width is a prognostic marker of perioperative stroke in patients undergoing cardiac valve surgery. Interact Cardiovasc Thorac Surg 2017;25:925-929.
116. Shao Q, Korantzopoulos P, Letsas KP, et al. Red blood cell distribution width as a predictor of atrial fibrillation. J Clin Lab Anal 2018;32:e22378.
117. Ferreira JP, Girerd N, Arrigo M, et al. Enlarging red blood cell distribution width during hospitalization identifies a very high-risk subset of acutely decompensated heart failure patients and adds valuable prognostic information on top of hemoconcentration. Medicine 2016;95:e3307.
118. Kim CH, Park JT, Kim EJ, et al. An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Critic Care 2013;17:R282.
119. Zoller B, Melander O, Svensson P, Engstrom G. Red cell distribution width and risk for venous thromboembolism: A population-based cohort study. Thromb Res 2014;133: 334-339.
120. Spiropoulos A, Goussetis E, Margeli A, et al. Effect of inflammation induced by prolonged exercise on circulating erythroid progenitors and markers of erythropoiesis. Clin Chem Lab Med 2010;48:199-203.
121. Bozkurt B, Mann DL, Deswal A. Biomarkers of inflammation in heart failure. Heart Fail Rev 2010;15:331-341.
122. Okonko DO, Marley SB, Anker SD, Poole-Wilson PA, Gordon MY. Suppression of erythropoiesis in patients with chronic heart failure and anaemia of unknown origin: Evidence of an immune basis. Int J Cardiol 2013;166: 664-671.
123. Shemin D, Rittenberg D. The life span of the human red blood cell. J Biol Chem 1946;166:627-636.
124. Azab B, Torbey E, Hatoum H, et al. Usefulness of red cell distribution width in predicting all-cause long-term mortality after non-ST-elevation myocardial infarction. Cardiology 2011;119:72-80.
125. Mozos I. Mechanisms linking red blood cell disorders and cardiovascular diseases. BioMed Res Int 2015;2015: 682054.
126. Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: A simple parameter with multiple clinical applications. Critic Rev Clin Lab Sci 2015;52:86-105.
127. Hou H, Sun T, Li C, et al. An overall and dose-response meta-analysis of red blood cell distribution width and CVD outcomes. Sci Rep 2017;7:43420.
128. Cha MJ, Lee HS, Kim HM, Jung JH, Choi EK, Oh S. Association between red cell distribution width and thromboembolic events in patients with atrial fibrillation. Eur J Int Med 2017;46:41-46.
129. Arbel Y, Weitzman D, Raz R, et al. Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study. Thromb Haemost 2014;111:300-307.
130. van der Meer P, Postmus D, Ponikowski P, et al. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 2013;61:1973-1981.
131. Davila C, Reyentovich A, Katz SD. Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure. J Card Fail 2011;17:1018-1022.
132. Tziakas DN, Chalikias GK, Stakos D, et al. Independent and additive predictive value of total cholesterol content of erythrocyte membranes with regard to coronary artery disease clinical presentation. Int J Cardiol 2011;150:22-27.
133. Zhang Y, Wang Y, Kang JS, et al. Differences in the predictive value of red cell distribution width for the mortality of patients with heart failure due to various heart diseases. J Geriatr Cardiol 2015;12:647-654.
134. Xanthopoulos A, Giamouzis G, Melidonis A, et al. Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus. Cardiovasc Diabetol 2017;16:81.
135. Sanchez-Chaparro MA, Calvo-Bonacho E, Gonzalez-Quintela A, et al. Higher red blood cell distribution width is associated with the metabolic syndrome: Results of the Ibermutuamur CArdiovascular RIsk assessment study. Diabetes Care 2010;33:e40.
136. Solak Y, Yilmaz MI, Saglam M, et al. Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease. Am J Med Sci 2014;347:118-124.
137. Engstrom G, Smith JG, Persson M, Nilsson PM, Melander O, Hedblad B. Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus. J Intern Med 2014;276:174-183.
138. Di Pietro N, Giardinelli A, Sirolli V, et al. Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients. Mol Cell Biochem 2016;417:155-167.
139. Angelini F, Pagano F, Bordin A, Picchio V, De Falco E, Chimenti I. Getting old through the blood: Circulating molecules in aging and senescence of cardiovascular regenerative cells. Front Cardiovasc Med 2017;4:62.
140. Angelini F, Pagano F, Bordin A, et al. The impact of environmental factors in influencing epigenetics related to oxidative states in the cardiovascular system. Oxidative Med Cell Longevity 2017;2017:2712751.
141. van der Putten K, Braam B, Jie KE, Gaillard CA. Mechanisms of Disease: Erythropoietin resistance in patients with both heart and kidney failure. Nat Clin Pract Nephrol 2008;4:47-57.
142. Emans ME, van der Putten K, van Rooijen KL, et al. Determinants of red cell distribution width (RDW) in cardiorenal patients: RDW is not related to erythropoietin resistance. J Card Fail 2011;17:626-633.
143. Kucera M, Balaz D, Kruzliak P, et al. The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators-A pilot study. Clin Biochem 2015;48:557-561.
144. Xiong XF, Yang Y, Chen X, et al. Red cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients. Sci Rep 2017;7:2709.
145. Poglajen G, Sever M, Cernelc P, Haddad F, Vrtovec B. Increased red cell distribution width is associated with poor stem cell mobilization in patients with advanced chronic heart failure. Biomarkers 2015;20:365-370.
146. Rodriguez-Carrio J, Alperi-Lopez M, Lopez P, et al. Red cell distribution width is associated with endothelial progenitor cell depletion and vascular-related mediators in rheumatoid arthritis. Atherosclerosis 2015;240:131-136.
147. De Falco E, Avitabile D, Totta P, et al. Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus. J Cell Mol Med 2009;13:3405-3414.
148. De Falco E, Carnevale R, Pagano F, et al. Role of NOX2 in mediating doxorubicin-induced senescence in human endothelial progenitor cells. Mech Ageing Dev 2016;159:37-43.
149. De Falco E, Porcelli D, Torella AR, et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004; 104:3472-3482.
150. Shay JW. Telomeres and aging. Curr Opin Cell Biol 2017; 52:1-7.
151. Diez Roux AV, Ranjit N, Jenny NS, et al. Race/ethnicity and telomere length in the Multi-Ethnic Study of Atherosclerosis. Aging Cell 2009;8:251-257.
152. Martorana A, Balistreri CR, Bulati M, et al. Double negative (CD19+IgG+IgD-CD27-) B lymphocytes: A new insight from telomerase in healthy elderly, in centenarian offspring and in Alzheimer's disease patients. Immunol Lett 2014;162:303-309.
153. Rizvi S, Raza ST, Mahdi F. Telomere length variations in aging and age-related diseases. Curr Aging Sci 2014;7: 161-167.
154. Balistreri CR, Pisano C, Martorana A, et al. Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals? Age 2014;36:9700.
155. Balistreri CR, Pisano C, Merlo D, et al. Is the mean blood leukocyte telomere length a predictor for sporadic thoracic aortic aneurysm? Data from a preliminary study. Rejuvenation Res 2012;15:170-173.
156. Mazidi M, Penson P, Banach M. Association between telomere length and complete blood count in US adults. Arch Med Sci 2017;13:601-605.
157. Mather KA, Jorm AF, Parslow RA, Christensen H. Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci 2011;66:202-213.
158. Sanders JL, Newman AB. Telomere length in epidemiology: A biomarker of aging, age-related disease, both, or neither? Epidemiol Rev 2013;35:112-131.
159. Chilton W, O'Brien B, Charchar F. Telomeres, Aging and Exercise: Guilty by Association? Int J Mol Sci 2017;18, pii:E2573.
160. Danise P, Maconi M, Barrella F, et al. Evaluation of nucleated red blood cells in the peripheral blood of hematological diseases. Clin Chem Lab Med 2011;50:357-360.
161. Monteiro Junior JG, Torres Dde O, da Silva MC, et al. Nucleated red blood cells as predictors of all-cause mortality in cardiac intensive care unit patients: A Prospective Cohort Study. PLoS One 2015;10:e0144259.
162. Hwang SY, Lee JH, Lee YH, Hong CK, Sung AJ, Choi YC. Comparison of the Sequential Organ Failure Assessment, Acute Physiology and Chronic Health Evaluation II scoring system, and Trauma and Injury Severity Score method for predicting the outcomes of intensive care unit trauma patients. Am J Emerg Med 2012;30:749-753.
163. Olivieri F, Pompilio G, Balistreri CR. Endothelial progenitor cells in ageing. Mech Ageing Dev 2016;159:1-3.
164. Regina C, Panatta E, Candi E, et al. Vascular ageing and endothelial cell senescence: Molecular mechanisms of physiology and diseases. Mech Ageing Dev 2016;159:14-21.
165. Madonna R, Novo G, Balistreri CR. Cellular and molecular basis of the imbalance between vascular damage and repair in ageing and age-related diseases: As biomarkers and targets for new treatments. Mech Ageing Dev 2016; 159:22-30.
166. Balistreri CR, Madonna R, Melino G, Caruso C. The emerging role of Notch pathway in ageing: Focus on the related mechanisms in age-related diseases. Ageing Res Rev 2016;29:50-65.
167. Dhingra R, Vasan RS. Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers. Trends Cardiovasc Med 2017;27:123-133.
168. Balistreri CR, Buffa S, Pisano C, Lio D, Ruvolo G, Mazzesi G. Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and Perspectives. Biomed Res Int 2015;2015: 835934.
169. Balistreri CR (Ed.). Endothelial progenitor cells (EPCs) in ageing and age-related diseases: From their physiological and pathological implications to translation in personalized medicine [Special issue]. Mech Ageing Devolop 2016;159:49-62.
170. Balistrieri CR. Endothelial Progenitor Cells: A New Real Hope or Only an Unrealizable Dream? Dordrecht, Springer International Publishing, 2017, pp. 1-80.
171. Balistrieri CR. An overview on adult stem/progenitor cells as potential drivers of tissue ageing/disease: Endothelial progenitor cells as typical examples J Hematol Clin Ther 2018;1:8-11.